Bankruptcy Judge Approves Sale of HDL, Inc. to True Health Diagnostics, LLC

True Health CEO says his company looks forward to utilizing HDL’s “among the best in the business” diagnostic technologies

RICHMOND, Va. (September 16, 2015) – United States Bankruptcy Judge Kevin R. Huennekens today gave final approval for the $37.1 million sale of substantially all of the business assets of Health Diagnostic Laboratory Inc. (HDL, Inc.) to True Health Diagnostics, LLC. The two companies anticipate completing the transaction by the end of the month.

True Health CEO Chis Grottenthaler said, “We are extremely pleased that the bankruptcy judge has approved the sale of HDL, Inc. to True Health. The diagnostic technology developed by HDL, Inc. is among the best in the business, and we look forward to utilizing it in combination with our existing technologies to offer innovative, state-of-the-art medical science to physicians and their patients.

“We are adopting an exacting corporate compliance program that, along with rigorous controls and intensive sales force training, will ensure that True Health will meet and exceed all regulatory requirements. We look forward to the steady, measured growth of our company and delivering excellent service to those using our services.”

HDL, Inc. CEO and President Joe McConnell commented, “Given the circumstances, the sale of HDL, Inc. to True Health is an exciting outcome for both our employees and the continued use of HDL, Inc.’s technology in the ongoing battle against cardiovascular disease and diabetes.”

HDL, Inc. Executive Vice President and General Counsel Douglas Sbertoli said, “HDL, Inc. did not panic when faced with adversity. We set forth a plan and executed it. Today’s approval by Judge Huennekens of the sale to True Health facilitates a quick exit from the bankruptcy process, and aids us in achieving what has been our primary goal throughout this process: maximizing the value of HDL, Inc. assets for the benefit of our creditors and other stakeholders.”

True Health was named by HDL, Inc. as the “stalking horse bidder” on Sept. 4, and it increased its initial bid of $32 million by $5.1 million in the course of a Sept. 10 court supervised section 363 auction proceeding in which multiple bids were submitted. The sale was subject to today’s final approval by the bankruptcy judge.

True Health, a privately held company headquartered in Frisco, Texas, is an innovative diagnostics company focused on preventing chronic disease in order to empower physicians and other medical specialists to achieve better patient health outcomes. It specializes in advanced clinical laboratory testing, which enables healthcare providers to more accurately diagnose, manage, and prevent the progression of cardiovascular diseases, genetic disorders, diabetes, and other metabolic conditions.

About Health Diagnostic Laboratory, Inc.
Founded in 2008, Health Diagnostic Laboratory, Inc. (HDL, Inc.) is a leader in health management with one primary mission: prevent and reverse heart disease and diabetes, one patient at a time. The company offers a comprehensive test menu of biomarkers that can indicate risk for cardiovascular disease, diabetes, and related diseases. HDL, Inc.’s systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing healthcare providers to better manage the health of their patients. In addition to lab testing, HDL, Inc. offers patients a personalized overview of risk factors and assistance from expert Clinical Health Consultants to promote healthy, longer-lasting lifestyles. The company also provides comprehensive testing and wellness services to employers and is a partner for value-based, integrated care models and health systems. HDL, Inc. is a CLIA-certified, CAP-accredited laboratory. For more information, visit, and make HDL, Inc. part of your digital lifestyle at and on Twitter @hdltweets.

MEDIA CONTACT: Doug Sbertoli at or (804) 343-2718 ext. 1635.

Press Releases

Bankruptcy Judge Approves Sale of HDL, Inc. to True Health Diagnostics, LLC

True Health Offers $37.1 Million in Successful Bid to Acquire HDL, Inc.

HDL, Inc. Reaches Agreement with True Health to Serve as “Stalking Horse Bidder” in Court-Supervised Sale of Company

HDL, Inc. Begins Utilizing DIP Financing

HDL, Inc. Seeks Court Approval to Sell the Company

More Press Releases >>